Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's diseaseNOORDIJK, E. M; CARDE, P; HENRY-AMAR, M et al.Annals of oncology. 1994, Vol 5, pp 107-112, issn 0923-7534, SUP2Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas : results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhCM-CSFENGELHARD, M; GERHARTZ, H; LUDWIG, W.-D et al.Annals of oncology. 1994, Vol 5, pp 123-125, issn 0923-7534, SUP2Conference Paper

Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomasHAGEMEISTER, F. B; KHETAN, R; ALLEN, P et al.Annals of oncology. 1994, Vol 5, pp 41-46, issn 0923-7534, SUP2Conference Paper

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients : a case-controlled analysis of the EBMT Registry dataLIBERTI, G; PEARCE, R; TAGHIPOUR, G et al.Annals of oncology. 1994, Vol 5, pp 151-153, issn 0923-7534, SUP2Conference Paper

Early-stage Hodgkin's disease : long-term results with radiotherapy alone or combined radiotherapy and chemotherapyBRUSAMOLINO, E; LAZZARINO, M; CORBELLA, F et al.Annals of oncology. 1994, Vol 5, pp 101-106, issn 0923-7534, SUP2Conference Paper

High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma : the EBMT experienceSWEETENHAM, J. W; PROCTOR, S. J; BLAISE, D et al.Annals of oncology. 1994, Vol 5, pp 155-159, issn 0923-7534, SUP2Conference Paper

Hybrid LOPP/EVA is not better than LOPP alternating with EVAP : a prematurely terminated British National Lymphoma Investigation randomized trialHANCOCK, B. W; VAUGHAN HUDSON, G; BAUGHAN HUDSON, B et al.Annals of oncology. 1994, Vol 5, pp 117-120, issn 0923-7534, SUP2Conference Paper

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphomaROHATINER, A. Z. S; FREEDMAN, A; NADLER, L et al.Annals of oncology. 1994, Vol 5, pp 143-146, issn 0923-7534, SUP2Conference Paper